JORDAN FORSTHOFF: Open Payments
NPI 1972759777 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,653 in 78 payments from 14 companies in 2025. Trend: 2023 $640 · 2024 $671 · 2025 $1,653
Food & beverage: $1,653
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $270 |
| Sumitomo Pharma America, Inc. | 12 | $226 |
| Astellas Pharma US Inc | 8 | $199 |
| MAYNE PHARMA COMMERCIAL LLC | 6 | $197 |
| MILLICENT US INC | 11 | $169 |
| PFIZER INC. | 8 | $141 |
| Sage Therapeutics, LLC | 5 | $99 |
| Exeltis, USA Inc. | 5 | $84 |
| SHIELD THERAPEUTICS INC | 4 | $76 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $56 |
Products named: MYFEMBREE, QULIPTA, Veozah, ABRYSVO, ANNOVERA, FEMLYV, ZURZUVAE, SLYND.
Industry payments across LA — which companies pay providers there.
